Journal article · 2023 · Open access

Persistent serum protein signatures define an inflammatory subcategory of long COVID

Aarthi Talla, Suhas V. Vasaikar, Gregory Lee Szeto, Maria P. Lemos, Julie Czartoski, Hugh Macmillan, Zoe Moodie, Kristen W. Cohen, Lamar Ballweber-Fleming, Zachary Thomson, Lauren Y. Okada, Lynne A. Becker and 8 more

Nature Communications, 14(1), 3417 · Published 9 June 2023 · DOI 10.1038/s41467-023-38682-4

Open PDFView at the publisherCite this paper

In brief

“Persistent serum protein signatures define an inflammatory subcategory of long COVID” is a 2023 journal article by Aarthi Talla and 19 co-authors, published in Nature Communications. OpenAlex counts 147 citations as of 21 November 2026, which puts it in the top 1% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Nature Communications.

Citations
147
Most cited in
2024 (50)
Field-weighted impact
21.38
References
55
Authors
20

Abstract

Long COVID or post-acute sequelae of SARS-CoV-2 (PASC) is a clinical syndrome featuring diverse symptoms that can persist for months following acute SARS-CoV-2 infection. The aetiologies may include persistent inflammation, unresolved tissue damage or delayed clearance of viral protein or RNA, but the biological differences they represent are not fully understood. Here we evaluate the serum proteome in samples, longitudinally collected from 55 PASC individuals with symptoms lasting ≥60 days after onset of acute infection, in comparison to samples from symptomatically recovered SARS-CoV-2 infected and uninfected individuals. Our analysis indicates heterogeneity in PASC and identified subsets with distinct signatures of persistent inflammation. Type II interferon signaling and canonical NF-κB signaling (particularly associated with TNF), appear to be the most differentially enriched signaling pathways, distinguishing a group of patients characterized also by a persistent neutrophil activation signature. These findings help to clarify biological diversity within PASC, identify participants with molecular evidence of persistent inflammation, and highlight dominant pathways that may have diagnostic or therapeutic relevance, including a protein panel that we propose as having diagnostic utility for differentiating inflammatory and non-inflammatory PASC.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Talla, A., Vasaikar, S. V., Szeto, G. L., Lemos, M. P., Czartoski, J., Macmillan, H., Moodie, Z., Cohen, K. W., Ballweber-Fleming, L., Thomson, Z., Okada, L. Y., Becker, L. A., Coffey, E. M., De Rosa, S. C., Newell, E. W., Skene, P. J., Li, X., Bumol, T. F., McElrath, M. J., & Torgerson, T. R. (2023). Persistent serum protein signatures define an inflammatory subcategory of long COVID. Nature Communications, 14(1), 3417. https://doi.org/10.1038/s41467-023-38682-4

MLA 9

Talla, Aarthi, et al. “Persistent serum protein signatures define an inflammatory subcategory of long COVID.” Nature Communications, vol. 14, no. 1, 2023, p. 3417. https://doi.org/10.1038/s41467-023-38682-4.

Chicago

Talla, Aarthi, Suhas V. Vasaikar, Gregory Lee Szeto, Maria P. Lemos, Julie Czartoski, Hugh Macmillan, Zoe Moodie, et al. 2023. “Persistent serum protein signatures define an inflammatory subcategory of long COVID.” Nature Communications 14 (1): 3417. https://doi.org/10.1038/s41467-023-38682-4.

Harvard

Talla, A. et al. (2023) ‘Persistent serum protein signatures define an inflammatory subcategory of long COVID’, Nature Communications, 14(1), p. 3417. doi:10.1038/s41467-023-38682-4.

IEEE

A. Talla et al., “Persistent serum protein signatures define an inflammatory subcategory of long COVID,” Nature Communications, vol. 14, no. 1, p. 3417, 2023, doi: 10.1038/s41467-023-38682-4.

BibTeX

@article{talla2023persistent,
  title     = {{Persistent serum protein signatures define an inflammatory subcategory of long COVID}},
  author    = {Talla, Aarthi and Vasaikar, Suhas V. and Szeto, Gregory Lee and Lemos, Maria P. and Czartoski, Julie and Macmillan, Hugh and Moodie, Zoe and Cohen, Kristen W. and Ballweber-Fleming, Lamar and Thomson, Zachary and Okada, Lauren Y. and Becker, Lynne A. and Coffey, Ernest M. and De Rosa, Stephen C. and Newell, Evan William and Skene, Peter J. and Li, Xiaojun and Bumol, Thomas F. and McElrath, M. Juliana and Torgerson, Troy R.},
  journal   = {Nature Communications},
  year      = {2023},
  volume    = {14},
  number    = {1},
  pages     = {3417},
  doi       = {10.1038/s41467-023-38682-4},
  url       = {https://doi.org/10.1038/s41467-023-38682-4}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20231616
20245050
20254444
20263737

Its field-weighted citation impact is 21.38: it has been cited 21.38 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19

  • long COVID
  • chronic inflammation
  • serum proteome
  • proteomic signatures
  • type II interferon signaling
  • NF-κB signaling
  • TNF-α
  • neutrophil activation

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Talla, A., Vasaikar, S. V., Szeto, G. L., Lemos, M. P., Czartoski, J., Macmillan, H., Moodie, Z., Cohen, K. W., Ballweber-Fleming, L., Thomson, Z., Okada, L. Y., Becker, L. A., Coffey, E. M., De Rosa, S. C., Newell, E. W., Skene, P. J., Li, X., Bumol, T. F., McElrath, M. J., & Torgerson, T. R. (2023). Persistent serum protein signatures define an inflammatory subcategory of long COVID. Nature Communications, 14(1), 3417. https://doi.org/10.1038/s41467-023-38682-4

How many times has this paper been cited?

147 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Nature Communications: sign in and open the PDF from this page.

Who wrote this paper?

Aarthi Talla, Suhas V. Vasaikar, Gregory Lee Szeto, Maria P. Lemos, Julie Czartoski, Hugh Macmillan, Zoe Moodie, Kristen W. Cohen, Lamar Ballweber-Fleming, Zachary Thomson, Lauren Y. Okada, Lynne A. Becker and 8 more.

What is the DOI of this paper?

10.1038/s41467-023-38682-4, permanently at https://doi.org/10.1038/s41467-023-38682-4. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.